References :
- Hermans C, Weill A, Pierce GF. The COVID-19 pandemic: New global challenges for the haemophilia community. Haemophilia 2020; 26(3): 371-2.
- Franchini M, Mannucci PM. The history of hemophilia. Semin Thromb Hemost 2014; 40(5): 571-6.
- George LA, Sullivan SK, Giermasz A, Rasko JEJ, Samelson-Jones BJ, Ducore J, et al. Hemophilia B gene therapy with a high-specific-activity factor IX variant. N Engl J Med 2017; 377(23): 2215-27.
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
- Pierce GF, Haffar A, Ampartzidis G, Peyvandi F, Diop S, El-Ekiaby M, et al. First-year results of an expanded humanitarian aid programme for haemophilia in resource-constrained countries. Haemophilia 2018; 24(2): 229-35.
- Chang L, Yan Y, Wang L. Coronavirus disease 2019: Coronaviruses and blood safety. Transfus Med Rev 2020; 34(2): 75-80.
- Kulkarni R. Use of telehealth in the delivery of comprehensive care for patients with haemophilia and other inherited bleeding disorders. Haemophilia 2018; 24(1): 33-42.
Health challenges of hemophilia patients during coronovirus
2019 epidemic
Rahbar Karbasdehi E.1, Rahbar Karbasdehi F.1
1Faculty of Literature and Humanities, University of Guilan, Rasht, Iran
Received: 18 Sep 2021
Accepted: 3 Dec 2021
Correspondence: Rahbar Karbasdehi E., M.A of Psychology and Education of Exceptional Children. Faculty of Literature and Humanities, University of Guilan.
Postal Code: 4199613776, Rasht, Iran. Tel: (+9813) 33829044; Fax: (+9813) 33829044
E-mail:
Ebrahim.Rahbar74@gmail.com